White Paper
As care management programs supported by RPM move toward system-wide, multi-condition deployments, RPM solutions must be able to cost-effectively scale across the enterprise. As a result, payers and providers require solutions that serve the entirety of their population – from high risk to rising risk and diabetes to hypertension. No longer will disease-specific solutions support the growing versatility and flexibility required of RPM. Fully meeting these requirements and offering broad device and data integration capabilities, Frost & Sullivan recognizes Validic Impact for its customer value, leadership, and product innovation in the North American payer and provider markets.